trastuzumab (Herceptin); listed in the CCLE (ref 18232) 生物安全等级 BSL-1 细胞规格 1×106cells/T25培养瓶或者1mL冻存管包装 支原体检测 无 基因表达情况 培养基 DMEM+10%FBS+1%P/S 培养条件 气相:空气,95%;CO2,5%, 温度:37℃ 冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:...
trastuzumab (Herceptin); listed in the CCLE (ref 18232) 年龄(性别) 女性;62岁 细胞类型 肿瘤细胞 肿瘤类型 乳腺导管癌 生物安全等级 BSL-1 倍增时间 ~30-40 hours (DSMZ=ACC-589); 35.39 hours (GrayJW panel) 保藏机构 AddexBio; C0006005/50 DSMZ; ACC-589 运输和保存: 干冰运输及复苏好存活细胞 ...
Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells. Cancer Lett. 2010;294(2):211-219.Koninki, K., Barok, M., Tanner, M., Staff, S., Pitkanen, J., Hemmila, P., Ilvesaro, J. and Isola, J. (2010) Multiple Mo- lecular ...
trastuzumab (Herceptin); listed in the CCLE (ref 18232) 年龄(性别) 女,62岁 细胞类型 肿瘤细胞 肿瘤类型 乳腺导管癌 生物安全等级 1 倍增时间 ~30-40 hours (DSMZ=ACC-589); 35.39 hours (GrayJW panel) 保藏机构 AddexBio; C0006005/50 DSMZ; ACC-589 二、细胞培养操作 1) 复苏细胞:以下细胞培养...
human epidermal growth factor receptor 2 (Her/2)epidermal growth factor receptor (EGFR)selenium (Se)antibody drug conjugate (ADC)monoclonal antibody (mab)Herceptin (R)Trastuzumab (Tz)Kadcyla (R) (T-DM-1)superoxide (O-2(center dot-))
Cytotoxic Effects of Seleno-Trastuzumab on Transtuzumab resistant JIMT-1 Breast Cancer Cell Line Bapat P.1, Goswami D.1, Shastri A.1, Boylan M.1, Zapada K.2, Cobos E.2, Plano D.3, Sharma A.K.3 Spallholz J.1 1Texas Tech University, Nutrition, Lubbock, United States, 2Texas Tech...
2 - Cytotoxic Effects of Seleno-Trastuzumab on Transtuzumab Resistant JIMT-1 Breast Cancer Cell Linedoi:10.1016/j.freeradbiomed.2013.10.415PriyankaBapatDebalinaGoswamiAnuradhaShastriMalloryBoylanKristopherZapadaSDOSFree Radical Biology & Medicine